Central Nervous System News and Research

RSS

Nail salon workers face underestimated risks from chemical exposure

Nail salon workers in New York City face greater health risks on the job than previously understood, according to a new study published in the journal Risk Analysis.

5 Nov 2026

Faulty cellular recycling may link pulmonary arterial hypertension to brain damage

A commentary in The Journal of Clinical Investigation examines evidence linking pulmonary arterial hypertension (PAH) to cerebellar abnormalities, focusing on impaired lysosomal lipid metabolism, oxysterol accumulation, and microglial inflammation. Findings from human imaging, mouse models, and cultured cells suggest that NCOA7 may help protect against these changes, although the proposed mechanisms and therapeutic implications require further investigation.

4 Nov 2026

New pediatric consensus standardizes surgical management of Wilms tumor

WT outcomes have improved substantially through progress in molecular diagnosis, chemotherapy, radiotherapy, and surgery. Yet surgical management remains inconsistent, especially for large tumors, adjacent-organ invasion, intravascular extension, nephron-sparing surgery (NSS), and lymph node biopsy.

2 Nov 2026

Skin organoids reveal how herpes simplex virus spreads between cells

Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced in skin organoids, how herpes simplex virus 1 infection progresses among neighboring skin cells, deepening our understanding.

30 Oct 2026

Excessive exercise disrupts dopamine regulation in the brain, study finds

Excessive physical exercise affects more than just the muscles; it can also alter brain chemistry. A new study published in the journal Neuroscience revealed that exhaustive training without adequate rest alters the regulation of dopamine in the hippocampus, a brain region closely linked to memory and the regulation of emotions.

30 Oct 2026

Gut microbial catalog reveals systemic inflammation drivers in spinal injury

Scientists exploring the links between a spinal cord injury, inflammation and immune function have turned their attention to a genome-level analysis of the gut microbial community, with early study results offering hints at potential new approaches to aid healing.

30 Oct 2026

New metabolic score may help predict healthy aging and disease risk

Studies conducted in various countries indicate that approximately 60% of people over the age of 65 currently live with two or more chronic conditions simultaneously.

29 Oct 2026

New Yale initiative explores the role of inflammation in disease

Yale School of Medicine (YSM) was awarded a $10 million grant from the Blavatnik Family Foundation (BFF) to launch a new research initiative in the field of inflammation science.

29 Oct 2026

Novel transporter protein discovery opens new pathways for central nervous system therapies

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.

29 Oct 2026

Mosquito bite prevention helps protect children from West Nile virus

In warm climates like Southern California, multiple species of mosquitoes can bite year-round. While telltale red, itchy bumps are the most common side effect of mosquito bites, these pests can also pass diseases, like West Nile virus, on to humans.

28 Oct 2026

Evolutionary history reveals why brains connect to opposite bodies

Dr Martin Wessendorf is a neuroscientist and an associate professor emeritus at the University of Minnesota. His work focuses on how the brainstem controls the function of neurons in the spinal cord.

27 Oct 2026

Researchers develop versatile genetic tool to investigate cell interactions

Our bodies are composed of many different types of cells that work together to build and maintain normal physiological functions.

27 Oct 2026

Marine-derived compound shows promise against deadly brain eating amoeba

Primary amoebic meningoencephalitis (PAM), a parasitic disease that causes the rapid deterioration of brain tissue, is one of the most lethal infections known, with a fatality rate exceeding 97%.

26 Oct 2026

NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma

Today, the National Comprehensive Cancer Network (NCCN) published the first-ever edition of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Bone Sarcoma.

1 Oct 2026

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Researchers from University of California San Diego have received a $12.6 million award from the National Institute on Drug Abuse (NIDA) to establish the Polysubstance Addiction Research Center (PARC), a multidisciplinary center designed to uncover the biological factors that contribute to addiction across multiple substances.

30 Sep 2026

Declining benzodiazepine use reflects more cautious medical prescribing practices

The number of benzodiazepine prescriptions like Xanax and Valium dispensed in the United States decreased over the past 10 years, potentially suggesting that doctors have become more cautious when prescribing these sedatives, according to Rutgers Health researchers.

30 Sep 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026